Ari Buchler brings operational and governance perspectives to STI's
HALIFAX, April 6 /CNW/ - STI, the pioneer and leader in transactional
marketing solutions for the Canadian healthcare market, is pleased to
welcome Ari Buchler, an experienced senior executive with an
operational, transactional, legal and administration background, to its
Board of Directors.
The Halifax-based, venture backed company was looking to add someone
with relevant international experience to compliment the existing
board. Mr. Buchler has extensive experience working with various
companies in legal aspect roles, most recently as Senior Vice
President, Legal and Regulatory Services at Phase Forward Incorporated.
Mr. Buchler joined Phase Forward in 1999 and helped lead the company
through venture financings, M&A, IPO and its ultimate sale to Oracle
Corporation in August 2010.
"A world-class Board is a key component of our growth strategy. Ari,
through his Phase Forward journey, has lived though the phases of
growth that STI is now entering," says Steve Nicolle, CEO of STI. "And
he will bring a real-time perspective from New England, a major region
in both the venture and pharmaceutical industries."
The local company has grown substantially over the past two years, and
seen success in their quest to be Canada's leader in transactional
marketing and the board is integral to this growth. In addition to
legal expertise, Mr. Buchler brings with him experience and knowledge
from sitting on a number of Advisory Boards in the healthcare and
"STI is tackling some of the most pressing challenges facing healthcare
industry stakeholders," says Mr. Buchler. "I have been impressed with
STI's innovation and leadership and I am excited to weigh in on their
practices and strategy as part of the Board of Directors."
STI (www.smartsti.com) is a Halifax, N.S. based company that provides innovative healthcare
marketing solutions across the lifecycle of pharmaceutical and device brands, using its
SmartTechnology™ platform as the source of real-time transactional
intelligence to allow all stakeholders - manufacturer, pharmacy,
prescriber, and payer - to optimize their patient relationships. STI
has contracted with over 60 customers for a total of over 300 programs
in the market to give patients and healthcare providers greater
convenience by providing an enhanced pharmacy medication and device
reimbursement process that is built on the safe delivery of healthcare
through retail pharmacies across Canada.
SOURCE STI (SAMPLING TECHNOLOGIES INC.)
For further information:
Mary Jane Leslie, Marketing Associate